Pharmafile Logo
Pharmafocus logo
Advanced Search
scott_gottlieb_getty_images

Former FDA Commissioner Scott Gottlieb elected to Pfizer’s Board of Directors

June 28, 2019
Medical Communications FDA, Pfizer, Scott Gottlieb, pharma

Dr Scott Gottlieb, who stepped down from his role as the 23rd Commissioner of the FDA earlier this year, has …

News
shutterstock_158366573

Healthcare communications: Time to think differently with patient centricity

June 27, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Spink, patient centricity, pharma

Patient centricity, derived from the NHS-driven thinking “no decision about me, without me”, has been adopted by pharma to understand …

Feature
512px-hpv_causing_cervical_cancer

Major review points to success of HPV vaccine, cervical cancer could be eradicated in developed nations

June 27, 2019
Research and Development Cancer, HPV, UK, cervical cancer, human papilloma virus, pharma, vaccines

A major new review published in The Lancet has supported the effectiveness of the human papilloma virus (HPV) vaccine in …

News
dw-anzcxqaqavhl

FDA approves Dupixent for chronic rhinosinusitis with nasal polyposis

June 27, 2019
Sales and Marketing Dupixent, FDA, Sanofi, US, pharma, rhinosinusitis

Regeneron Pharmaceuticals and Sanofi have revealed that their dual IL-4 and IL-13 inhibitor Dupixent (dupilumab) has secured FDA approval in …

News
opioid_therapy_credit_-_us_air_force_valerie_monroy

Titan Therapeutics’ opioid dependence implant Sixmo approved in Europe

June 27, 2019
Sales and Marketing Molteni, Sixmo, Titan Therapeutics, pharma

The European Commission has awarded marketing approval to Sixmo, a subdermal buprenorphine implant from Titan Therapeutics and Molteni, in all …

News
astrazeneca-sign

AstraZeneca’s Imfinzi meets endpoint at Phase 3 interim analysis in extensive-stage small cell lung cancer

June 27, 2019
Research and Development AstraZeneca, Imfinzi, pharma

AstraZeneca has lifted the curtain on new Phase 3 data for Imfinzi (durvalumab) in the first-line treatment of extensive-stage small …

News
takeda_deerfield_hq

Takeda plans to vacate all 1,000 staff from US HQ by the year’s end

June 26, 2019
Manufacturing and Production, Medical Communications, Sales and Marketing Shire, Takeda, US, pharma

Takeda has announced its plans to vacate all staff from its US headquarters in Deerfield, Illinois, by the end of …

News
antibiotic_sensitvity_and_resistance

Rare Group A strep outbreak kills 12 and infects 20 in Essex

June 26, 2019
Medical Communications, Research and Development England, NHS, UK, outbreak, pharma

An outbreak of the rare contagious bacteria Group A streptococcal (iGAS) infection in Essex, UK, has resulted in 32 cases …

News
novartis_side_building

Novartis provides promising update on Cosentyx in plaque psoriasis

June 26, 2019
Research and Development Cosentyx, Novartis, pharma, psoriasis

Novartis has revealed brief new data on its IL-17A antibody Cosentyx (secukinumab) in the treatment off plaque psoriasis, showing that …

News
acer_therapeutics

Acer’s shares drop 80% as FDA rejects drug for vascular Ehlers-Danlos syndrome

June 26, 2019
Research and Development, Sales and Marketing Acer Therapeutics, Edsivo, pharma

Acer Therapeutics has seen its share value plunge by 80% after it emerged that the FDA had turned down its …

News
shutterstock_273326141

AbbVie poised to acquire Allergan for $63 billion

June 26, 2019
Research and Development, Sales and Marketing AbbVie, Allergan, acqusition, pharma

The industry has been rocked with the announcement of another pharmaceutical mega-merger, as it emerged that AbbVie had sealed an …

News

China urges firms to make generic versions of 34 drugs

June 25, 2019
Research and Development China, NHC, generic drugs, generics, patents, pharma

China’s National Health Commission (NHC) has urged generic drugmakers to pick up the production of 34 drugs that are not …

News
w36

FREE WEBINAR: Virtually engaged or engaged virtually?

June 25, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, Within3, pharma

In just over a week, on Wednesday 4 July, Pharmafocus will be collaborating with Healthcare Engagement Solutions firm Within3 to …

News

FDA knocks back Glenmark’s allergic rhinitis therapy Ryaltris

June 25, 2019
Manufacturing and Production, Sales and Marketing FDA, Glenmark, Ryaltris, US, allergy, pharma

Stocks in Indian pharmaceutical firm Glenmark were sent plummeting to a six-year low after it was confirmed that the FDA …

News
mental-health-3332122_960_720

Minerva’s insomnia treatment beats Ambien in Phase 2b trial

June 25, 2019
Manufacturing and Production MDD, Minerva Neurosciences, Placebo, ambien, insomnia, pharma, zolpidem

Massachusetts-based firm Minerva Neurosciences has announced that its sleeping pill seltorexant beat both Sanofi’s Ambien (zolpidem) and placebo in treating …

News
40773627633_110a1e516d_z

Kamala Harris hopes to make insurance companies cover PrEP at no out-of-pocket cost to patients

June 25, 2019
Manufacturing and Production, Sales and Marketing

Democratic presidential candidate Kamala Harris has introduced a bill which would require all private and public insurance plans to cover …

News
bms_nassau_park_new_jersey

Bristol-Myers Squibb to sell off Celgene’s Otezla ahead of $74 billion merger

June 24, 2019
Manufacturing and Production Bristol-Myers Squibb, Celgene, FTC, otezla, pharma, psoriasis

Bristol-Myers Squibb has agreed to sell off Celgene’s psoriasis treatment Otezla, to appease antitrust regulators. BMS will divest one of …

News
brexit

The Brexit ‘cliff edge’: How life sciences can survive

June 24, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, brexit, pharma

Characterised by a persistent lack of clarity and a political climate that has everyone guessing from week to week, Brexit …

Feature

Pfizer’s Talzenna approved in Europe for HER2- advanced breast cancer with gBRCA1/2 mutations

June 24, 2019
Sales and Marketing Pfizer, breast cancer, oncology, pharma

Pfizer’s oral poly (ADP-ribose) polymerase (PARP) inhibitor Talzenna (talazoparib) has secured approval in Europe from the European Commission, the drugmaker …

News
novartis_window

Glenmark signs deal with Novartis over distribution in Brazil

June 24, 2019
Sales and Marketing Brazil, Glenmark, Latin America, Novartis, distribution, pharma

Indian firm Glenmark Pharmaceuticals has entered into an agreement with Novartis over the distribution of its respiratory products in Brazil. …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026